Portal de Periódicos da CAPES

ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

2012; Elsevier BV; Volume: 18; Linguagem: Inglês

10.1111/1469-0691.12038

1469-0691

Manuel Cuenca‐Estrella, Paul E. Verweij, Maiken Cavling Arendrup, Sevtap Arıkan-Akdağlı, Jacques Billé, J. Peter Donnelly, Henrik Elvang Jensen, Cornelia Lass‐Flörl, Malcolm Richardson, Murat Akova, Matteo Bassetti, Thierry Calandra, Elio Castagnola, Oliver A. Cornely, Jorge Garbino, Andreas H. Groll, Raoul Herbrecht, William Hope, Bart Jan Kullberg, Olivier Lortholary, Wouter Meersseman, G. Petrikkos, Emmanuel Roilides, Claudio Viscoli, Andrew J. Ullmann,

Respiratory and Cough-Related Research

As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.